发明名称 |
CANCER THERAPY |
摘要 |
The present application relates to compositions and methods for treating a proliferative disorder by administering to a subject a pharmaceutical composition of a dual kinase inhibitor metabolite. Catecholic butane metabolites can serve as dual kinase inhibitors for purposes of methods described herein. Proliferative diseases are a serious threat to modem society. Cancerous growths, including malignant cancerous growth, pose serious challenges for modem medicine due to their unique characteristics. |
申请公布号 |
CA2941010(A1) |
申请公布日期 |
2014.09.04 |
申请号 |
CA20142941010 |
申请日期 |
2014.02.26 |
申请人 |
TRIACT THERAPEUTICS, INC. |
发明人 |
WHITE, THOMAS F.;SMITH, STEVEN |
分类号 |
A61K31/7034;A61K31/661;A61P35/00;G01N33/48 |
主分类号 |
A61K31/7034 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|